EGFR and medulloblastoma: Taken together, these data show that EGFR/HER2 signaling can be activated by EGF in DAOY cells and thus, DAOY cells may serve as a suitable model to test the effect of cardiac glycosides on EGFR signaling in medulloblastoma.